Four ESCEO-AMGEN Osteoporosis Fellowships, each valued at USD 50,000, were awarded to young researchers working in Belgium, Canada, UK and Switzerland.
The following award winners, selected on the basis of their outstanding research proposals, were announced on the second day of the World Congress on Osteoporosis 2010 (IOF WCO-ECCEO10) taking place in Florence, Italy until May 8, 2010:
The Fellowship Programme is offered by Amgen in cooperation with the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). It aims to develop and enhance the opportunities for physicians or PhD's who are training for careers in osteoporosis, with the goal of furthering advances in clinical care and prevention.
ABOUT ESCEO
The European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) is a non-profit organization, dedicated to a close interaction between clinical scientists dealing with rheumatic disorders, pharmaceutical industry developing new compounds in this field, regulators responsible for the registration of such drugs and health policy makers, to integrate the management of osteoporosis and osteoarthritis within the comprehensive perspective of health resources utilization. The objective of ESCEO is to provide practitioners with the latest clinical and economic information, allowing them to organize their daily practice, in an evidence-based medicine perspective, with a cost-conscious perception. http://www.esceo.org